Philips Patient Information Center iX input validation
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Philips Patient Information Center iX, PerformanceBridge Focal Point and IntelliVue Patient Monitor. It has been declared as problematic. The impacted element is an unknown function. Executing a manipulation can lead to input validation. This vulnerability is handled as CVE-2020-16216. The attack can only be done within the local network. There is not any exploit available.
Details
A vulnerability classified as problematic was found in Philips Patient Information Center iX, PerformanceBridge Focal Point and IntelliVue Patient Monitor (Medical Device Software) (version now known). This vulnerability affects some unknown processing. The manipulation with an unknown input leads to a input validation vulnerability. The CWE definition for the vulnerability is CWE-20. The product receives input or data, but it does
not validate or incorrectly validates that the input has the
properties that are required to process the data safely and
correctly. As an impact it is known to affect availability. CVE summarizes:
In IntelliVue patient monitors MX100, MX400-550, MX600, MX700, MX750, MX800, MX850, MP2-MP90, and IntelliVue X2 and X3 Versions N and prior, the product receives input or data but does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly, which can induce a denial-of-service condition through a system restart.
The weakness was released 09/11/2020 (Website). The advisory is available at us-cert.cisa.gov. This vulnerability was named CVE-2020-16216 since 07/31/2020. The exploitation appears to be easy. Access to the local network is required for this attack to succeed. No form of authentication is required for a successful exploitation. The technical details are unknown and an exploit is not available.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Entries connected to this vulnerability are available at VDB-161130, VDB-161131, VDB-161132 and VDB-161133. If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.philips.ch/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.4
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.5
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Input validationCWE: CWE-20
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
07/31/2020 🔍09/11/2020 🔍
09/11/2020 🔍
02/24/2026 🔍
Sources
Vendor: philips.chAdvisory: us-cert.cisa.gov
Status: Not defined
CVE: CVE-2020-16216 (🔍)
GCVE (CVE): GCVE-0-2020-16216
GCVE (VulDB): GCVE-100-161146
See also: 🔍
Entry
Created: 09/11/2020 21:56Updated: 02/24/2026 05:03
Changes: 09/11/2020 21:56 (36), 09/11/2020 21:59 (18), 02/24/2026 05:03 (18)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.